StockNews.AI
OMI
StockNews.AI
189 days

Owens & Minor Launches ByramConnect Digital Health Platform for Diabetes and Other Chronic Health Conditions

1. ByramConnect launched, aiding diabetes management through AI-driven insights. 2. FDA-cleared platform supports chronic condition monitoring for diabetes patients. 3. Enhanced patient care with real-time feedback and access to health data. 4. Improves health outcomes across diabetes and associated conditions through digital coaching. 5. Byram serves nearly three million patients with a wide product portfolio.

8m saved
Insight
Article

FAQ

Why Bullish?

The launch of ByramConnect enhances OMI's service offerings and can attract more users, akin to how expansions or innovations positively impacted similar healthcare companies in the past.

How important is it?

The article highlights a significant development in OMI's product offerings that can drive future revenue and strengthen its market position.

Why Long Term?

Long-term benefits from increased patient engagement and improved health outcomes align with OMI's mission, similar to past enhancements leading to sustained growth.

Related Companies

OMIWLDI
RICHMOND, Va.--(BUSINESS WIRE)--Byram Healthcare, a leader in home-based care and part of the Owens & Minor (NYSE: OMI) family, recently launched ByramConnectTM, a personalized digital health program powered by the Welldoc App®. Using the Welldoc App’s advanced artificial intelligence capabilities, the program analyzes member data across six dimensions of health to help optimize outcomes for people with type 1 or type 2 diabetes and associated chronic conditions such as hypertension, weight management, and cardiovascular risk, providing Byram members with actionable insights and reports that can be shared with their providers and care teams. “Chronic health conditions like diabetes are complex and can have long-term health implications that require multiple supportive interventions over the course of a member’s care journey,” said Perry Bernocchi, EVP and CEO, Patient Direct, Owens & Minor. “We’re proud to offer Byram members a clinically validated platform designed to help them achieve concrete goals, such as weight management and improved control over their diabetes, in addition to longer-lasting behavior changes that help support a lifetime of better overall health.” ByramConnect powered by the Welldoc App is a U.S. Food and Drug Administration (FDA)-cleared class II software as a medical device (SaMD) intended for use by healthcare providers and adult patients with type 1 or type 2 diabetes*. In clinical studies, patients using the app saw improvements in several important measures related to their condition, including reduced (A1C), lower blood pressure and lower body weight.1-4 The ByramConnect platform offers Byram diabetes customers access to the Welldoc App, which provides their care teams a holistic view of their condition by combining patient-tracked health data and connected sources such as fitness trackers, blood glucose meters, continuous glucose monitors (CGMs), blood pressure monitors, scales, heart rate monitors and medical labs and pharmacies. Additional ByramConnect powered by the Welldoc App benefits include: Digital coaching: personalized, AI-driven digital coaching providing real-time feedback and coaching based on a patient’s unique data and trends Diet and nutrition support: tracking, insights and guidance to help promote healthy eating habits, including meal planning and restaurant recommendations based on dietary requirements GLP-1 medication support: support to help patients manage medications, monitor potential side-effects and track adherence over time Reporting & insights: health reports with actionable insights based on the patient’s unique data, patterns and trends that patients can share with their provider and care team Mental wellbeing: guidance and reinforcement to help members manage overall wellbeing, including mood, sleep and anxiety *Welldoc Diabetes and Welldoc Diabetes Rx is an FDA-cleared medical device, intended for use by healthcare providers and their adult patients with type 1 or type 2 diabetes. For full labeling information, visit www.welldoc.com. The other Welldoc App products are non-FDA-cleared and intended to promote general wellness and education/self-management of various chronic disease states. ByramConnect powered by the Welldoc App can be used on any device and is available now as an included service exclusively for Byram diabetes customers at no additional charge. Byram customers will receive an invitation via email within the next couple of weeks with an exclusive access code allowing them to download the app from the Apple or Google Play App stores. More information about ByramConnect powered by the Welldoc App can be found at byramhealthcare.com/byram-connect-powered-by-welldoc. About Owens & Minor Owens & Minor, Inc. (NYSE: OMI) is a Fortune 500 global healthcare solutions company providing essential products and services that support care from the hospital to the home. For over 100 years, Owens & Minor and its affiliated brands, Apria®, Byram® and HALYARD*, have helped to make each day better for the patients, providers and communities we serve. Powered by more than 20,000 teammates worldwide, Owens & Minor delivers comfort and confidence behind the scenes so healthcare stays at the forefront. Owens & Minor exists because every day, everywhere, Life Takes Care™. For more information about Owens & Minor and our affiliated brands, visit owens-minor.com or follow us on LinkedIn and Instagram. *Registered Trademark or Trademark of O&M Halyard or its affiliates. About Byram Byram Healthcare (“Byram” or “Byram Healthcare Centers, Inc.”), part of the Owens & Minor family, delivers the products, services and support patients need to help improve health outcomes and affordability of care in the home. Along with Apria, Byram Healthcare makes up the Owens & Minor Patient Direct business segment, which serves nearly three million patients each year and offers one of the broadest portfolios of products for chronic and acute conditions including diabetes, wound care, sleep health, respiratory care, urology and ostomy care. For more information, visit byramhealthcare.com. About Welldoc® Welldoc, a digital health leader revolutionizing cardiometabolic care, is integrating personalized, real-time and actionable insights into the daily lives of individuals living with cardiometabolic conditions, enabling improved health and outcomes. Welldoc’s comprehensive digital health platform provides AI-powered digital coaching across pre-diabetes, diabetes, hypertension, heart failure and weight and obesity management, with integrated mental wellbeing and sleep support. The Welldoc App is an FDA-cleared digital health solution that guides individuals through the complicated journey of living with diabetes by enabling them to self-manage their care while enhancing connections to their healthcare team. For more information, visit www.welldoc.com. ______________ 1. Quinn, et al. Diabetes Care (2011). 2. Kumbara et al. Diabetes Technology (2022). 3. Welldoc Data on File. 4. CDC. Workplace Health Promotion (2022). OMI-CORP OMI-IR

Related News